These in vitro results were confirmed by clinical findings that high TGF-β3 mRNA levels are associated with extra-pelvic spread, disease progression, and poor progression-free survival (PFS) and overall survival (OS) of ovarian cancer patients. The gene discussed is TGFB3; the disease is ovarian cancer.